1. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence
- Author
-
Fox, Caroline S, Golden, Sherita Hill, Anderson, Cheryl, Bray, George A, Burke, Lora E, de Boer, Ian H, Deedwania, Prakash, Eckel, Robert H, Ershow, Abby G, Fradkin, Judith, Inzucchi, Silvio E, Kosiborod, Mikhail, Nelson, Robert G, Patel, Mahesh J, Pignone, Michael, Quinn, Laurie, Schauer, Philip R, Selvin, Elizabeth, and Vafiadis, Dorothea K
- Subjects
Clinical Research ,Heart Disease ,Nutrition ,Cardiovascular ,Diabetes ,Prevention ,Metabolic and endocrine ,Good Health and Well Being ,American Heart Association ,Cardiovascular Diseases ,Diabetes Mellitus ,Type 2 ,Humans ,Practice Guidelines as Topic ,Primary Prevention ,Randomized Controlled Trials as Topic ,Risk Factors ,United States ,American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health ,Council on Clinical Cardiology ,Council on Cardiovascular and Stroke Nursing ,Council on Cardiovascular Surgery and Anesthesia ,Council on Quality of Care and Outcomes Research ,and the American Diabetes Association ,AHA Scientific Statements ,cardiovascular disease ,diabetes ,primary prevention ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Public Health and Health Services ,Cardiovascular System & Hematology - Abstract
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.
- Published
- 2015